By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Providing discovery research technology to enable the discovery of next-generation therapeutics18.67M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States of America18.67M100.00%